Company: NDRA
Filing Date: 2025-11-26
Form Type: 424B4
Source: 0001213900-25-115097
Chunk: 11

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-26
Form: 424B4
Chunk 11
---
 that may be obtained from, our website is not, and shall not be deemed to be, a part of this prospectus.

<div align='center'>3</div>

The Offering

| Shares of common stock offered by the selling 
 stockholders                                  |     | We are registering the resale                                                                                                        
 by the selling stockholders of an aggregate of 2,677,680 shares of common stock, consisting of (i) 379,539 PIPE Shares (ii) 364,801  
 Pre-Funded Warrant Shares, (iii) 1,488,680 Common Warrant Shares, (iv) 400,000 Arca Warrant Shares and (v) 44,660 Placement Agent    
 Warrant Shares.                                                                                                                      |
| Terms of the offering                         |     | Each selling stockholder will determine                                                                                              
 when and how it will sell the common stock offered in this prospectus, as described in “Plan of Distribution.”                       |
| Use of proceeds                               |     | We will not receive any of the proceeds                                                                                              
 from the sale of the Shares in this offering. The selling stockholders will receive all of the proceeds from this offering. We will, 
 however, receive the proceeds of any cash exercises of the Warrants.                                                                 |
| Risk Factors                                  |     | See “Risk Factors” on page                                                                                                           
 5 for a discussion of factors you should carefully consider before deciding to invest in our common stock.                           |
| Nasdaq ticker symbol                          |     | “NDRA”                                                                                                                               |

<div align='center'>4

RISK FACTORS</div>

An investment in our securities involves a number of risks. Before deciding to invest in our securities, you should carefully consider the risks described in the sections captioned “Risk Factors” contained in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, as filed with the SEC, which are incorporated by reference herein in their entirety and any other subsequently filed document that is also incorporated or deemed to be incorporated by reference in this prospectus. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be harmed. This could cause the trading price of our common stock to decline, resulting in a loss of all or part of your investment. The risks described in the documents referenced above are not the only ones that we face. Additional risks not presently known to us or that we currently deem immaterial may also affect our business. For more information, see the below section